000759850 000__ 03317cam\a2200457Ii\4500
000759850 001__ 759850
000759850 005__ 20230306141936.0
000759850 006__ m\\\\\o\\d\\\\\\\\
000759850 007__ cr\cn\nnnunnun
000759850 008__ 160729s2016\\\\sz\a\\\\o\\\\\001\0\eng\d
000759850 020__ $$a9783319335551$$q(electronic book)
000759850 020__ $$a3319335553$$q(electronic book)
000759850 020__ $$z9783319335537
000759850 0247_ $$a10.1007/978-3-319-33555-1$$2doi
000759850 035__ $$aSP(OCoLC)ocn954214796
000759850 035__ $$aSP(OCoLC)954214796
000759850 040__ $$aN$T$$beng$$erda$$epn$$cN$T$$dYDXCP$$dIDEBK$$dEBLCP$$dGW5XE$$dAZU$$dCOO$$dN$T
000759850 049__ $$aISEA
000759850 050_4 $$aRC394.D35
000759850 08204 $$a616.8/047548$$223
000759850 08204 $$a610
000759850 24500 $$aMagnetic resonance spectroscopy of degenerative brain diseases$$h[electronic resource] /$$cGülin Öz, editor.
000759850 264_1 $$aSwitzerland :$$bSpringer,$$c2016.
000759850 300__ $$a1 online resource (xv, 268 pages) :$$billustrations.
000759850 336__ $$atext$$btxt$$2rdacontent
000759850 337__ $$acomputer$$bc$$2rdamedia
000759850 338__ $$aonline resource$$bcr$$2rdacarrier
000759850 4901_ $$aContemporary clinical neuroscience
000759850 500__ $$aIncludes index.
000759850 5050_ $$aImaging Neurodegeneration: What can Magnetic Resonance Spectroscopy Contribute? -- Methodology of MRS in animal models: Technical challenges and solutions -- Methodology of clinical MRS: Technical challenges and solutions -- Magnetic Resonance Spectroscopy in Dementia -- Magnetic Resonance Spectroscopy in Parkinsonian Disorders -- Magnetic Resonance Spectroscopy in Huntington's Disease -- Magnetic Resonance Spectroscopy in Motor Neuron Diseases -- Magnetic Resonance Spectroscopy in Multiple Sclerosis -- Magnetic Resonance Spectroscopy in Ataxias -- Magnetic Resonance Spectroscopy in Prion Diseases -- Magnetic Resonance Spectroscopy in HIV-Associated Neurocognitive Disorders (HAND) -- Magnetic Resonance Spectroscopy in Epilepsy.
000759850 506__ $$aAccess limited to authorized users.
000759850 520__ $$aThe proposed book will act as a guide for scientists and clinicians to the unique information that MRS can provide. It will be a comprehensive overview of clinical and pre-clinical MRS applications and potential clinical utility of MRS biomarkers in degenerative brain diseases from leading experts in the field. MRS has proven to be a powerful complementary tool to MRI for the diagnosis and monitoring of disease progression and response to treatment because it can detect changes in cell density, cell type, and biochemical composition, not just structural changes. As the population in the developed world continues to age, neuroimaging for diagnosis, prognosis, and therapy monitoring of neurodegenerative diseases becomes increasingly important and there has been a recent surge of clinical and pre-clinical applications of MRS indicating that this technique can provide robust and non-invasive biomarkers of degeneration.
000759850 588__ $$aOnline resource; title from PDF title page (SpringerLink, viewed August 8, 2016).
000759850 650_0 $$aBrain$$xDegeneration$$xMagnetic resonance imaging.
000759850 7001_ $$aÖz, Gülin,$$eeditor.
000759850 77608 $$iPrint version:$$z9783319335537
000759850 830_0 $$aContemporary clinical neuroscience.
000759850 852__ $$bebk
000759850 85640 $$3SpringerLink$$uhttps://univsouthin.idm.oclc.org/login?url=http://link.springer.com/10.1007/978-3-319-33555-1$$zOnline Access$$91397441.1
000759850 909CO $$ooai:library.usi.edu:759850$$pGLOBAL_SET
000759850 980__ $$aEBOOK
000759850 980__ $$aBIB
000759850 982__ $$aEbook
000759850 983__ $$aOnline
000759850 994__ $$a92$$bISE